The European Union's drug regulatory agency on Thursday recommended the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11 years old.
Driving the news: The European Medicines Agency said the dose for kids "will be lower than that used in people aged 12 and above," per a press release from the agency.
Get market news worthy of your time with Axios Markets. Subscribe for free.
They cited a study in children ages 5 to 11 that found the vaccine to be 90.7% effective at preventing symptomatic COVID-19.
The recommendation will be sent to the European Commission, which will issue a final decision.
The big picture: The announcement comes after the CDC earlier this month recommended Pfizer shots for kids of the same age group.
What to watch: Pfizer and BioNTech said they have submitted requests for authorization of their COVID-19 vaccine for kids to other regulators around the world.
The companies say they also expect initial pivotal data from their ongoing clinical trial in children 2 to 5 years old this quarter and in kids aged 6 months to 2 years in the first quarter of 2022.
More from Axios: Sign up to get the latest market trends with Axios Markets. Subscribe for free